Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vickers

Showing results (631-640 of 665) with videos related to

Pageof 67
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2010
The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative GroupAndrew J Vickers, Angel M Cronin, Monique J Roobol, et al.
JCO Clinical Cancer Informatics|March 3, 2022
Gynecologic Survivorship Tool: Development, Implementation, and Symptom OutcomesJeanne Carter, Nadeem R Abu-Rustum, Sally Saban, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2024
Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation TherapyMark D Reardon, Becky A S Bibby, Niluja Thiruthaneeswaran, et al.
Practical Radiation Oncology|June 16, 2026
Prophylactic versus therapeutic sucralfate in patients at high risk for radiation esophagitis: randomized controlled trialJacob Y Shin, Melissa Assel, Abraham J Wu, et al.
World Journal of Urology|December 29, 2011
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative groupMonique J Roobol, F H Schröder, Jonas Hugosson, et al.
ESMO Open|August 3, 2022
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumorsE Borazanci, A M Schram, E Garralda, et al.
Plos Pathogens|September 16, 2024
Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic E. coli adhesinZachary T Berndsen, Marjahan Akhtar, Mahima Thapa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 27, 2026
Associations between body composition and radiotherapy-related side-effects and health-related quality of life in patients with prostate or lung cancer: sub-analysis of the REQUITE trialAlexander J Vickers, Donal M McSweeney, Ananya Choudhury, et al.
World Journal of Urology|January 3, 2012
Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative GroupDonna P Ankerst, Andreas Boeck, Stephen J Freedland, et al.
The Lancet. Oncology|June 17, 2022
MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre studyBehfar Ehdaie, Clare M Tempany, Ford Holland, et al.
Pageof 67

Showing results (631-640 of 665) with videos related to

Sort By:
Pageof 67
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2010
The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative GroupAndrew J Vickers, Angel M Cronin, Monique J Roobol, et al.
JCO Clinical Cancer Informatics|March 3, 2022
Gynecologic Survivorship Tool: Development, Implementation, and Symptom OutcomesJeanne Carter, Nadeem R Abu-Rustum, Sally Saban, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2024
Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation TherapyMark D Reardon, Becky A S Bibby, Niluja Thiruthaneeswaran, et al.
Practical Radiation Oncology|June 16, 2026
Prophylactic versus therapeutic sucralfate in patients at high risk for radiation esophagitis: randomized controlled trialJacob Y Shin, Melissa Assel, Abraham J Wu, et al.
World Journal of Urology|December 29, 2011
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative groupMonique J Roobol, F H Schröder, Jonas Hugosson, et al.
ESMO Open|August 3, 2022
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumorsE Borazanci, A M Schram, E Garralda, et al.
Plos Pathogens|September 16, 2024
Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic E. coli adhesinZachary T Berndsen, Marjahan Akhtar, Mahima Thapa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 27, 2026
Associations between body composition and radiotherapy-related side-effects and health-related quality of life in patients with prostate or lung cancer: sub-analysis of the REQUITE trialAlexander J Vickers, Donal M McSweeney, Ananya Choudhury, et al.
World Journal of Urology|January 3, 2012
Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative GroupDonna P Ankerst, Andreas Boeck, Stephen J Freedland, et al.
The Lancet. Oncology|June 17, 2022
MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre studyBehfar Ehdaie, Clare M Tempany, Ford Holland, et al.
Pageof 67